These findings suggest that lncRNA FOXD2-AS1 can promote the proliferation and migration of breast cancer cells, inhibit apoptosis, affect the drug resistance of breast cancer cells, and promote the malignant biological behavior of breast cancer. The gene discussed is FOXD2; the disease is breast carcinoma.